NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Esperion Stock Surges 57% as ARCHIMED Acquires Company for $1.1 Billion

ARCHIMED will buy Esperion and take it private for $3.16/share (+58% premium) plus up to $100M extra payouts if targets are met.

Esperion Stock Surges 57% as ARCHIMED Acquires Company for $1.1 Billion
Credit: Esperion
Already have an account? Sign in.
Featured/ 05/01/2026 · 8:37 AM
ESPR
/ Don’t stop at just one post.

Related↓

09/19/2025 · 10:02 AM

NEXLETOL Gains Approval in Japan: A Major Global Expansion for Esperion

Esperion's cholesterol pill, NEXLETOL, is now approved in Japan through its partner, Otsuka. This major global expansion (now U.S., Europe, Japan) secures Esperion large milestone payments and tiered royalties (15%-30%) on sales.

/ Subscriber only
/ Read more

Feed↓

Nebius Acquires Eigen AI to Make Token Factory the Fastest Inference Platform
Featured/ 05/01/2026 · 9:24 AM

Nebius Acquires Eigen AI to Make Token Factory the Fastest Inference Platform

Nebius is buying Eigen AI for $643M to make AI faster, cheaper, and improve real-time answers for businesses.

/ Subscriber only
Summit Therapeutics Drops 21%: The “Continue” News That Spooked Investors
05/01/2026 · 9:02 AM

Summit Therapeutics Drops 21%: The “Continue” News That Spooked Investors

Summit stock fell after its cancer drug update was just “keep going,” not the big win investors hoped for.

/ Subscriber only
Morgan Stanley Double Upgrades Paramount Skydance – Sees 37% Upside
Featured/ 05/01/2026 · 8:20 AM

Morgan Stanley Double Upgrades Paramount Skydance – Sees 37% Upside

Morgan Stanley upgraded PSKY, sees $14 target (+37%). Likes WBD merger + AI upside, but risks remain from debt & execution.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe